v3.26.3
Condensed Consolidated Statements of Shareholders' Equity - USD ($)
$ in Thousands
Ordinary Shares
Additional Paidin Capital
Accumulated Other Comprehensive Income (Loss)
Accumulated Deficit
Total
Beginning balance at Dec. 31, 2024 $ 890 $ 1,472,842 $ 119 $ (680,791) $ 793,060
Beginning balance (in shares) at Dec. 31, 2024 69,061,418        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon settlement of restricted share units $ 2       2
Issuance of ADSs upon settlement of restricted share units (in shares) 140,937        
Share-based compensation expense   9,605     9,605
Foreign currency translation adjustment     (1,580)   (1,580)
Net Income (Loss)       (60,754) (60,754)
Ending balance at Mar. 31, 2025 $ 892 1,482,447 (1,461) (741,545) 740,333
Ending balance (in shares) at Mar. 31, 2025 69,202,355        
Beginning balance at Dec. 31, 2024 $ 890 1,472,842 119 (680,791) 793,060
Beginning balance (in shares) at Dec. 31, 2024 69,061,418        
Increase (decrease) in shareholders' equity (deficit)          
Foreign currency translation adjustment         (3,590)
Net Income (Loss)         (198,806)
Ending balance at Sep. 30, 2025 $ 894 1,500,653 (3,471) (879,597) 618,479
Ending balance (in shares) at Sep. 30, 2025 69,306,511        
Beginning balance at Mar. 31, 2025 $ 892 1,482,447 (1,461) (741,545) 740,333
Beginning balance (in shares) at Mar. 31, 2025 69,202,355        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 51,589        
Share-based compensation expense   9,435     9,435
Foreign currency translation adjustment     (1,902)   (1,902)
Net Income (Loss)       (78,952) (78,952)
Ending balance at Jun. 30, 2025 $ 893 1,491,882 (3,363) (820,497) 668,915
Ending balance (in shares) at Jun. 30, 2025 69,253,944        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 52,567        
Share-based compensation expense   8,771     8,771
Foreign currency translation adjustment     (108)   (108)
Net Income (Loss)       (59,100) (59,100)
Ending balance at Sep. 30, 2025 $ 894 1,500,653 (3,471) (879,597) 618,479
Ending balance (in shares) at Sep. 30, 2025 69,306,511        
Beginning balance at Dec. 31, 2025 $ 894 1,512,339 (3,505) (899,751) $ 609,977
Beginning balance (in shares) at Dec. 31, 2025 69,367,896       69,367,896
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options   7     $ 7
Issuance of ADSs upon exercise of share options (in shares) 3,861        
Issuance of ADSs upon settlement of restricted share units $ 5       5
Issuance of ADSs upon settlement of restricted share units (in shares) 335,269        
Share-based compensation expense   6,930     6,930
Foreign currency translation adjustment     (1,774)   (1,774)
Net Income (Loss)       (60,825) (60,825)
Ending balance at Mar. 31, 2026 $ 899 1,519,276 (5,279) (960,576) 554,320
Ending balance (in shares) at Mar. 31, 2026 69,707,026        
Beginning balance at Dec. 31, 2025 $ 894 1,512,339 (3,505) (899,751) $ 609,977
Beginning balance (in shares) at Dec. 31, 2025 69,367,896       69,367,896
Increase (decrease) in shareholders' equity (deficit)          
Foreign currency translation adjustment         $ (1,832)
Net Income (Loss)         (121,636)
Ending balance at Sep. 30, 2026 $ 903 1,531,098 (5,337) (1,021,387) $ 505,277
Ending balance (in shares) at Sep. 30, 2026 69,993,013       69,993,013
Beginning balance at Mar. 31, 2026 $ 899 1,519,276 (5,279) (960,576) $ 554,320
Beginning balance (in shares) at Mar. 31, 2026 69,707,026        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options (in shares) 2,920        
Issuance of ADSs upon settlement of restricted share units $ 1       1
Issuance of ADSs upon settlement of restricted share units (in shares) 104,199        
Share-based compensation expense   6,404     6,404
Foreign currency translation adjustment     (137)   (137)
Net Income (Loss)       (50,333) (50,333)
Ending balance at Jun. 30, 2026 $ 900 1,525,680 (5,416) (1,010,909) 510,255
Ending balance (in shares) at Jun. 30, 2026 69,814,145        
Increase (decrease) in shareholders' equity (deficit)          
Issuance of ADSs upon exercise of share options (in shares) 9,251        
Issuance of ADSs upon settlement of restricted share units $ 3       3
Issuance of ADSs upon settlement of restricted share units (in shares) 169,617        
Share-based compensation expense   5,418     5,418
Foreign currency translation adjustment     79   79
Net Income (Loss)       (10,478) (10,478)
Ending balance at Sep. 30, 2026 $ 903 $ 1,531,098 $ (5,337) $ (1,021,387) $ 505,277
Ending balance (in shares) at Sep. 30, 2026 69,993,013       69,993,013